SGLT2 inhibition eliminates senescent cells and alleviates pathological aging.

In fact, short-term insulin treatment showed an increasing trend in the expression of cellular senescence markers and SASP factors, even though blood glucose was reduced to the same level as that of SGLT2 inhibitors.

also in 63,971 other papers